Articles published by Teva Pharmaceutical Industries Limited
![](https://mms.businesswire.com/media/20230518005378/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230515005044/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230510005122/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230509005164/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230503005145/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230428005389/en/739014/5/teva_RGB_JPEG.jpg)
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20230427005559/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230414005024/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230413005840/en/739014/5/teva_RGB_JPEG.jpg)
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20230411005179/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230327005150/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230313005492/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230306005799/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230307005198/en/739014/5/teva_RGB_JPEG.jpg)
Teva to Present at the Barclays Global Healthcare Conference
March 07, 2023
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20230301006056/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230226005206/en/739014/5/teva_RGB_JPEG.jpg)
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026
February 27, 2023
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20230226005205/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230223006032/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230223005296/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230217005357/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230207005854/en/739014/5/teva_RGB_JPEG.jpg)
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20230208005167/en/739014/5/teva_RGB_JPEG.jpg)
Teva Reports Fourth Quarter and Full Year 2022 Financial Results
February 08, 2023
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20230119005389/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230112005201/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230109005272/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230106005021/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20230103005134/en/739014/5/teva_RGB_JPEG.jpg)
Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
Via Business Wire
Tickers
TEVA
![](https://mms.businesswire.com/media/20221121005916/en/739014/5/teva_RGB_JPEG.jpg)
![](https://mms.businesswire.com/media/20221121005362/en/739014/5/teva_RGB_JPEG.jpg)
Teva Announces Appointment of Richard Francis as President and CEO
November 21, 2022
Via Business Wire
Tickers
TEVA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.